Suppr超能文献

血管紧张素II对催乳素分泌相关第二信使的作用由垂体前叶细胞中的AT1受体介导。

Angiotensin II effects on second messengers involved in prolactin secretion are mediated by AT1 receptor in anterior pituitary cells.

作者信息

Moreau C, Rasolonjanahary R, Audinot V, Kordon C, Enjalbert A

机构信息

U.M.R. 9941, CNRS-Université d'Aix Marseille II, Faculté de Médecine, France.

出版信息

Mol Cell Neurosci. 1994 Dec;5(6):597-603. doi: 10.1006/mcne.1994.1073.

Abstract

The two forms of angiotensin II (Ang II) receptors, AT1 and AT2 subtypes, have been demonstrated in many other cells beside the anterior pituitary cells. Attempting to investigate the subtype(s) of Ang II receptors implicated in the multiple transduction mechanisms involved in Ang II stimulation of prolactin (PRL) release by lactotropes, we studied the effect of selective nonpeptidergic Ang II antagonists on the PRL release, adenylate cyclase (AC), and phospholipase C activities. In intact cells, the AT1 antagonist DuP753 blocked Ang II-induced PRL release, reversed in a dose dependent manner Ang II-evoked inositol phosphates production, and inhibited completely the PLC and protein kinase C (PKC) dependent cAMP accumulation induced by Ang II. In membrane preparations, the Ang II receptors were negatively coupled to AC. The AT1 antagonist blocked in a dose dependent manner the inhibitory effect of Ang II on cAMP production. In intact cells, the negative coupling of Ang II receptor with AC was observed only when PKC was down regulated by long term 12-O-tetradecanolylphorbol-13-acetate pretreatment. Ang II was able to inhibit vasoactive intestinal peptide-induced cAMP accumulation, a response which was also prevented by DuP753. The different coupling of Ang II receptor described above implicated only the AT1 type receptor since the AT2 antagonists (PD123177 and PD123319) were ineffective at any doses tested (10(-8) to 10(-5) M). The obtained results indicate that the regulation of PRL secretion involves the AT1 receptor subtype and that this receptor might be coupled to multiple effectors.

摘要

血管紧张素II(Ang II)的两种受体形式,即AT1和AT2亚型,已在前垂体细胞之外的许多其他细胞中得到证实。为了研究参与Ang II刺激催乳素(PRL)由促乳素细胞释放的多种转导机制的Ang II受体亚型,我们研究了选择性非肽类Ang II拮抗剂对PRL释放、腺苷酸环化酶(AC)和磷脂酶C活性的影响。在完整细胞中,AT1拮抗剂DuP753阻断Ang II诱导的PRL释放,以剂量依赖方式逆转Ang II引起的肌醇磷酸生成,并完全抑制Ang II诱导的依赖PLC和蛋白激酶C(PKC)的cAMP积累。在膜制剂中,Ang II受体与AC呈负偶联。AT1拮抗剂以剂量依赖方式阻断Ang II对cAMP生成的抑制作用。在完整细胞中,仅当PKC通过长期12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯预处理下调时,才观察到Ang II受体与AC的负偶联。Ang II能够抑制血管活性肠肽诱导的cAMP积累,这种反应也被DuP753所阻止。上述Ang II受体的不同偶联仅涉及AT1型受体,因为AT2拮抗剂(PD123177和PD123319)在任何测试剂量(从10^(-8)到10^(-5) M)下均无效。所得结果表明,PRL分泌的调节涉及AT1受体亚型,并且该受体可能与多种效应器偶联。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验